Catabasis Pharmaceuticals Inc. (CATB) Dipped -5.03% or -0.03 To Price $0.59 On Friday


Catabasis Pharmaceuticals Inc. (CATB) dipped -5.03% or -0.03 to $0.59. It is near 137936 shares traded, which is 40.63% compare to the average total volume 339505. The market cap of CATB is $42.13 million. The year to date change is -63.94%. The 52 week price range is from $0.53 to $2.38. Price of CATB have changed 4.09% during last week. It have changed -3.17% over last month, -19.86% over last 3 months, -57.80% over last 6 months and -64.11% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CATB is 0.66. It is 11.86% above current price. The 200-day Moving Averages for CATB is 1.12. It is 89.83% above current price. The 52-week High is 2.38. It is 303.39% from the current price. The 52-week Low is 0.53. It is -10.17% from current price.

There are some statistics of CATB. It is has market cap $42.13 million. The share outstanding is 71.04 million. The average volume is 339505. The percent of top 15 Institution holding is 53.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CATB is -90.10%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CATB is -74.42%.


Tags:

Share this post